Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker CMPS
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | SCHEDULE 13G | CMPS COMPASS Pathways Plc | BIT Capital GmbH | 8.15M | 5.9% | SCHEDULE 13G ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Roderick Wong | 12.97M | 9.9% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | RTW Investments, LP | 12.97M | 9.9% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13D/A (amended) | CMPS COMPASS Pathways Plc | AtaiBeckley Inc. | 4.76M | 5.0% | SCHEDULE 13D/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Vivo Opportunity Cayman, LLC | 187,891 | 0.2% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Vivo Opportunity Cayman Fund, L.P. | 187,891 | 0.2% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Vivo Opportunity, LLC | 3.17M | 3.2% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Vivo Opportunity Fund Holdings, L.P. | 3.17M | 3.2% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Daniel Mack | 3.48M | 3.6% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Wilmot B. Harkey | 3.48M | 3.6% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Nantahala Capital Management, LLC | 3.48M | 3.6% | SCHEDULE 13G/A ↗ |
| Oct 29, 2025 | SCHEDULE 13D/A (amended) | CMPS COMPASS Pathways Plc | ATAI Life Sciences GmbH (formerly ATAI Life Sciences AG) | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Oct 29, 2025 | SCHEDULE 13D/A (amended) | CMPS COMPASS Pathways Plc | ATAI Life Sciences N.V. | 5.79M | 6.0% | SCHEDULE 13D/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Roderick Wong | 9.47M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | RTW Investments, LP | 9.47M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G | CMPS COMPASS Pathways Plc | Daniel Mack | 5.93M | 6.2% | SCHEDULE 13G ↗ |
| Aug 14, 2025 | SCHEDULE 13G | CMPS COMPASS Pathways Plc | Wilmot B. Harkey | 5.93M | 6.2% | SCHEDULE 13G ↗ |
| Aug 14, 2025 | SCHEDULE 13G | CMPS COMPASS Pathways Plc | Nantahala Capital Management, LLC | 5.93M | 6.2% | SCHEDULE 13G ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Chen Yu | 3.86M | 3.9% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | TCG Crossover Fund II, L.P. | 2.89M | 2.9% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | TCG Crossover GP II, LLC | 2.89M | 2.9% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | TCG Crossover Fund I, L.P. | 964,500 | 1.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | TCG Crossover GP I, LLC | 964,500 | 1.0% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Vivo Opportunity Cayman, LLC | 375,782 | 0.4% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Vivo Opportunity Cayman Fund, L.P. | 375,782 | 0.4% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Vivo Opportunity, LLC | 6.35M | 6.6% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Vivo Opportunity Fund Holdings, L.P. | 6.35M | 6.6% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G | CMPS COMPASS Pathways Plc | Roderick Wong, M.D. | 7.88M | 8.3% | SCHEDULE 13G ↗ |
| May 15, 2025 | SCHEDULE 13G | CMPS COMPASS Pathways Plc | RTW Investments, LP | 7.88M | 8.3% | SCHEDULE 13G ↗ |
| May 7, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Israel A. Englander | 2.77M | 3.0% | SCHEDULE 13G/A ↗ |
| May 7, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Millennium Group Management LLC | 2.77M | 3.0% | SCHEDULE 13G/A ↗ |
| May 7, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Millennium Management LLC | 2.77M | 3.0% | SCHEDULE 13G/A ↗ |
| May 7, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Integrated Core Strategies (US) LLC | 1.95M | 2.1% | SCHEDULE 13G/A ↗ |
| Apr 15, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Ekaterina Malievskaia | 2.16M | 2.3% | SCHEDULE 13G/A ↗ |
| Apr 15, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | George Jay Goldsmith | 2.24M | 2.4% | SCHEDULE 13G/A ↗ |
| Mar 5, 2025 | SCHEDULE 13D/A (amended) | CMPS COMPASS Pathways Plc | ATAI Life Sciences AG | 6.91M | 7.5% | SCHEDULE 13D/A ↗ |
| Mar 5, 2025 | SCHEDULE 13D/A (amended) | CMPS COMPASS Pathways Plc | ATAI Life Sciences N.V. | 6.91M | 7.5% | SCHEDULE 13D/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Kenneth Griffin | 1.17M | 1.7% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Citadel Securities GP LLC | 267,411 | 0.4% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Citadel Securities Group LP | 267,411 | 0.4% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Citadel Securities LLC | 267,411 | 0.4% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Citadel GP LLC | 899,165 | 1.3% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Citadel Advisors Holdings LP | 899,165 | 1.3% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Citadel Advisors LLC | 899,165 | 1.3% | SCHEDULE 13G/A ↗ |
| Feb 13, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Ekaterina Malievskaia | 2.31M | 2.5% | SCHEDULE 13G/A ↗ |
| Feb 13, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | George Jay Goldsmith | 2.37M | 2.6% | SCHEDULE 13G/A ↗ |
| Feb 6, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Israel A. Englander | 3.41M | 3.7% | SCHEDULE 13G/A ↗ |
| Feb 6, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Millennium Group Management LLC | 3.41M | 3.7% | SCHEDULE 13G/A ↗ |
| Feb 6, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Millennium Management LLC | 3.41M | 3.7% | SCHEDULE 13G/A ↗ |
| Feb 6, 2025 | SCHEDULE 13G/A (amended) | CMPS COMPASS Pathways Plc | Integrated Core Strategies (US) LLC | 3.11M | 3.4% | SCHEDULE 13G/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances